Jeffrey Quillen's varied business law practice focuses on companies involved with advanced technology applications. He serves as outside general counsel to a number of emerging biotechnology, software and information technology companies. For these and other clients he negotiates and drafts agreements regarding intellectual property rights, including patent license agreements with major research universities and collaboration agreements with pharmaceutical companies. On the financing side, Jeffrey represents venture capital funds and emerging companies in venture capital financing transactions, including private placements of convertible preferred stock and subordinated debt. He also represents buyers and sellers in mergers and acquisitions, involving public and private companies. His work in this area includes helping foreign companies to acquire U.S. companies and organize international operations. Professional / Civic Involvement · Boston Bar Association, Member · Peer Reviewer for the Massachusetts Life Sciences Center Accelerator Loan Program Speeches and Conferences · Moderator, "Building a Better Biotech," Mass High Tech Annual BioForum, February 17, 2011 · Speaker, "Founder Follies," Harvard Business School, February 10, 2011 · Moderator, "Nanomedicine: Next Generation of Blockbusters," BIO International Convention, May 3-5, 2010, Chicago, IL · Moderator, "High Risks, High Rewards: Avoiding the Pitfalls of Partnerships," Mass High Tech Annual BioForum, February 26, 2010 · Panelist, "Picking Winners and Losers in Health Care," Emerging Enterprise Center at Foley Hoag LLP, October 22, 2009 · Speaker, "2009 Financing Outlook," Emerging Enterprise Center at Foley Hoag LLP, September 21, 2009 · Speaker, "Key Issues in University/Hospital Spinouts of Life Sciences Companies," MCLE Cutting-Edge Life Sciences Law and Practice Seminar, March 9, 2009 · Moderator, "Outlook on Biotech: Survival Strategies," Mass High Tech's 7th Annual BioForum, February 5, 2009 · American Conference Institute's Managing Legal Risks In Pharmaceutical Manufacturing Outsourcing Conference, "Incorporating Audit Rights into the Contract to Ensure Maintenance of Quality, Performance and Protection of IP," November 18, 2008 · Panelist, "Build, Buy or Ally," New England Chapter of the Association of Strategic Alliance Professionals, September 17, 2008 · Chair, "Virtues and Vices of Virtual Biotechnology Companies," BIO 2008 International Convention, June 19, 2008 · Panelist, "Clinical Trials: Managing the Risk, Managing Expectations," William Gallagher Associates Conference, November 28, 2007 · Moderator, "The Coming Wave...Nanobiotechnology," Massachusetts Biotechnology Council, Annual Investors Conference, November 8, 2007 · Panelist, MIT Enterprise Forum of Cambridge Start-up Clinic, October 3, 2007 · Moderator, "Get Smart: Successful Strategies for Negotiating with Research Institutions," BIO International Convention, May 8, 2007 · Speaker, "Structuring the Milestone-Based Life Sciences Acquisition: Tails, Taxes and Control," American Conference Institute's Life Sciences Conference, March 14-15, 2007 · Speaker, "A Buyer's Guide to Managing the Due Diligence Process," American Conference Institute's IP Due Diligence Conference, January 30-31, 2006 and June 26-27, 2006 · Moderator, Harvard Medical School Early-Stage Life Sciences Technology Conference II, May 1, 2006 Publications · Top five things to consider when negotiating an R&D partnership, MASS HIGH TECH (January 17-23, 2005) · Costs and Benefits of Scientific Advisory Boards, FORUM REPORTER - THE NEWSLETTER OF THE MIT ENTERPRISE FORUM OF CAMBRIDGE (February 2004) · Creative Use of Milestones Can Unlock Venture Capital, FORUM REPORTER - THE NEWSLETTER OF THE MIT ENTERPRISE FORUM OF CAMBRIDGE (February 2003) Industries Venture Capital & Emerging Companies Life Sciences Licensing & Strategic Alliances Honors/Awards Listed in Best Lawyers in America® - Venture Capital Law (2007-2012 Editions) Listed in Boston's Best Lawyers® - Venture Capital Law (2008 & 2011 Editions) Endorsed by PLC Which Lawyer? for Venture Capital and Life Sciences: Commercial and Partnering (2007-2012 Editions) Listed in The Legal 500 US Volume 1 (Corporate & Finance) (2006) Listed in Super Lawyers - Massachusetts Rising Stars 2005 - Securities, Corporate Finance & IP |